Anjan K. Pradhan

1.3k citations

33 papers · 854 indexed · h-index 20

Co-authors: Paul B. Fisher Swadesh K. Das Luni Emdad Devanand Sarkar Praveen Bhoopathi Sarmistha Talukdar Xue‐Ning Shen Xiang‐Yang Wang
Topics: Virus-based gene therapy research (8 papers)Hippo pathway signaling and YAP/TAZ (8 papers)Axon Guidance and Neuronal Signaling (8 papers)
Cited by: Cancer Research Oncology Immunology
Journals: Proceedings of the National Academy of Sciences Cancer Research Oncogene
Partner nations: United States India Belgium

In The Last Decade

Anjan K. Pradhan

33 papers receiving 846 citations

Peers

Countries citing papers authored by Anjan K. Pradhan

Since Specialization

Citations

This map shows the geographic impact of Anjan K. Pradhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anjan K. Pradhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anjan K. Pradhan more than expected).

Fields of papers citing papers by Anjan K. Pradhan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anjan K. Pradhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anjan K. Pradhan. The network helps show where Anjan K. Pradhan may publish in the future.

Co-authorship network of co-authors of Anjan K. Pradhan

This figure shows the co-authorship network connecting the top 25 collaborators of Anjan K. Pradhan. A scholar is included among the top collaborators of Anjan K. Pradhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anjan K. Pradhan. Anjan K. Pradhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comprehensive meta-analysis of QTL and gene expression studies identify candidate genes associated with Aspergillus flavus resistance in maize 2023 ·Frontiers in Plant Science ·Niranjan Baisakh,(unknown),Anjan K. Pradhan,Kanniah Rajasekaran	8
2	A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistance 2023 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Subhayan Das,Moumita Kundu,(unknown),Aditya Parekh,Bikash Chandra Jena,(unknown),Indranil Banerjee,Y. Rajesh,Chandan Krushna Das,Anjan K. Pradhan,Swadesh K. Das,Luni Emdad,Pralay Mitra,Paul B. Fisher,Mahitosh Mandal	6
3	Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint Inhibitor 2022 ·Frontiers in Oncology ·Anjan K. Pradhan,Praveen Bhoopathi,Santanu Maji,Amit Kumar,Chunqing Guo,Padmanabhan Mannangatti,Jiong Li,Xiang‐Yang Wang,Devanand Sarkar,Luni Emdad,Swadesh K. Das,Paul B. Fisher	5
4	Engineering T Cells to Express Tumoricidal MDA-7/IL24 Enhances Cancer Immunotherapy 2021 ·Cancer Research ·Zheng Liu,Chunqing Guo,Swadesh K. Das,Xiaofei Yu,Anjan K. Pradhan,Xia Li,Yanxia Ning,Shixian Chen,Wenjie Liu,Jolene J. Windle,Harry D. Bear,Masoud H. Manjili,Paul B. Fisher,Xiang‐Yang Wang	12
5	Theranostic Tripartite Cancer Terminator Virus for Cancer Therapy and Imaging 2021 ·Cancers ·Praveen Bhoopathi,Anjan K. Pradhan,Santanu Maji,Swadesh K. Das,Luni Emdad,Paul B. Fisher	6
6	MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis 2020 ·Pharmacological Research ·Swadesh K. Das,Santanu Maji,(unknown),Praveen Bhoopathi,Anjan K. Pradhan,Sarmistha Talukdar,Devanand Sarkar,Joseph W. Landry,Chunqing Guo,Xiang‐Yang Wang,Webster K. Cavenee,Luni Emdad,Paul B. Fisher	38
7	MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein 2020 ·Cancer and Metastasis Reviews ·Anjan K. Pradhan,Santanu Maji,Swadesh K. Das,Luni Emdad,Devanand Sarkar,Paul B. Fisher	32
8	Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor 2019 ·Molecular Cancer Therapeutics ·Swadesh K. Das,Timothy P. Kegelman,Anjan K. Pradhan,(unknown),Praveen Bhoopathi,Sarmistha Talukdar,Santanu Maji,Devanand Sarkar,Luni Emdad,Paul B. Fisher	22
9	Recent insights into apoptosis and toxic autophagy: The roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic 2019 ·Seminars in Cancer Biology ·Luni Emdad,Praveen Bhoopathi,Sarmistha Talukdar,Anjan K. Pradhan,Devanand Sarkar,Xiang‐Yang Wang,Swadesh K. Das,Paul B. Fisher	71
10	MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of MITF 2019 ·Proceedings of the National Academy of Sciences ·Anjan K. Pradhan,Praveen Bhoopathi,Sarmistha Talukdar,(unknown),Devanand Sarkar,Webster K. Cavenee,Swadesh K. Das,Luni Emdad,Paul B. Fisher	23
11	Regulation of neuroblastoma migration, invasion, and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin 2019 ·Oncogene ·Praveen Bhoopathi,Anjan K. Pradhan,Manny D. Bacolod,Luni Emdad,Devanand Sarkar,Swadesh K. Das,Paul B. Fisher	25
12	Recombinant MDA-7/IL24 Suppresses Prostate Cancer Bone Metastasis through Downregulation of the Akt/Mcl-1 Pathway 2018 ·Molecular Cancer Therapeutics ·Anjan K. Pradhan,Praveen Bhoopathi,Sarmistha Talukdar,Xue‐Ning Shen,Luni Emdad,Swadesh K. Das,Devanand Sarkar,Paul B. Fisher	21
13	The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion 2018 ·Cancer Research ·Swadesh K. Das,Anjan K. Pradhan,Praveen Bhoopathi,Sarmistha Talukdar,Xue‐Ning Shen,Devanand Sarkar,Luni Emdad,Paul B. Fisher	42
14	The Enigma of miRNA Regulation in Cancer 2017 ·Advances in cancer research ·Anjan K. Pradhan,Luni Emdad,Swadesh K. Das,Devanand Sarkar,Paul B. Fisher	37
15	New Insights Into Beclin-1: Evolution and Pan-Malignancy Inhibitor Activity 2017 ·Advances in cancer research ·(unknown),Anjan K. Pradhan,Rob DeSalle,Swadesh K. Das,Luni Emdad,Devanand Sarkar,Paul B. Fisher	19
16	mda-7/IL-24 Mediates Cancer Cell–Specific Death via Regulation of miR-221 and the Beclin-1 Axis 2016 ·Cancer Research ·Anjan K. Pradhan,Sarmistha Talukdar,Praveen Bhoopathi,Xue‐Ning Shen,Luni Emdad,Swadesh K. Das,Devanand Sarkar,Paul B. Fisher	49
17	mda-7/IL-24 Induces Cell Death in Neuroblastoma through a Novel Mechanism Involving AIF and ATM 2016 ·Cancer Research ·Praveen Bhoopathi,Nathaniel Lee,Anjan K. Pradhan,Xue‐Ning Shen,Swadesh K. Das,Devanand Sarkar,Luni Emdad,Paul B. Fisher	31
18	Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy 2016 ·Cancer Letters ·Rashmi Bharti,Goutam Dey,Indranil Banerjee,Kaushik Dey,Sheetal Parida,B. N. Prashanth Kumar,Chandan Kanta Das,Ipsita Pal,M. Mukherjee,Mridula Misra,Anjan K. Pradhan,Luni Emdad,Swadesh K. Das,Paul B. Fisher,Mahitosh Mandal	66
19	Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis 2016 ·Oncotarget ·Swadesh K. Das,Chunqing Guo,Anjan K. Pradhan,Praveen Bhoopathi,Sarmistha Talukdar,Xue‐Ning Shen,Luni Emdad,Mark A. Subler,Jolene J. Windle,Devanand Sarkar,Xiang‐Yang Wang,Paul B. Fisher	24
20	Novel therapy of prostate cancer employing a combination of viral-based immunotherapy and a small molecule BH3 mimetic 2015 ·OncoImmunology ·Siddik Sarkar,Anjan K. Pradhan,Swadesh K. Das,Luni Emdad,Devanand Sarkar,Maurizio Pellecchia,Paul B. Fisher	7

About Anjan K. Pradhan

Anjan K. Pradhan is a scholar working on Cell Biology, Biotechnology and Oncology, having authored 33 papers that have together received 854 indexed citations. Recurring topics across this work include Virus-based gene therapy research (8 papers), Hippo pathway signaling and YAP/TAZ (8 papers) and Axon Guidance and Neuronal Signaling (8 papers). The work is most often cited by research in Cancer Research (206 citations), Oncology (239 citations) and Immunology (178 citations). Anjan K. Pradhan has collaborated with scholars based in United States, India and Belgium. Frequent co-authors include Paul B. Fisher, Swadesh K. Das, Luni Emdad, Devanand Sarkar, Praveen Bhoopathi, Sarmistha Talukdar, Xue‐Ning Shen, Xiang‐Yang Wang, Jolene J. Windle and Webster K. Cavenee. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact